Literature DB >> 20566324

Expression of neurotransmitter transporters for structural and biochemical studies.

Yael Elbaz1, Tsafi Danieli, Baruch I Kanner, Shimon Schuldiner.   

Abstract

Neurotransmitter transporters play essential roles in the process of neurotransmission. Vesicular neurotransmitter transporters mediate storage inside secretory vesicles in a process that involves the exchange of lumenal H(+) for cytoplasmic transmitter. Retrieval of the neurotransmitter from the synaptic cleft catalyzed by sodium-coupled transporters is critical for the termination of the synaptic actions of the released neurotransmitter. Our current understanding of the mechanism of these transporters is based on functional and biochemical characterization but is lacking high-resolution structural information. Very few structures of membrane transport systems from mammalian origin have been solved to atomic resolution, mainly because of the difficulty in obtaining large amounts of purified protein. Development of high yield heterologous expression systems suitable for mammalian neurotransmitter transporters is essential to enable the production of purified protein for structural studies. Such a system makes possible also the production of mutants that can be used in biochemical and biophysical studies. We describe here a screen for the expression of the vesicular monoamine transporter 2 (VMAT2) in cell-free and baculovirus expression systems and discuss the expression of VMAT2 in other systems as well (bacterial, yeast and mammalian cell lines). After screening and optimization, we achieved high yield (2-2.5 mg/l) expression of functional VMAT2 in insect cells. The system was also used for the expression of three additional plasma membrane neurotransmitter transporters. All were functional and expressed to high levels. Our results demonstrate the advantages of the baculovirus expression system for the expression of mammalian neurotransmitter transporters in a functional state. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20566324      PMCID: PMC2913170          DOI: 10.1016/j.pep.2010.06.001

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  48 in total

1.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

Authors:  N Takahashi; L L Miner; I Sora; H Ujike; R S Revay; V Kostic; V Jackson-Lewis; S Przedborski; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Structural conservation in the major facilitator superfamily as revealed by comparative modeling.

Authors:  Eyal Vardy; Isaiah T Arkin; Kay E Gottschalk; H Ronald Kaback; Shimon Schuldiner
Journal:  Protein Sci       Date:  2004-07       Impact factor: 6.725

3.  Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues.

Authors:  Chikashi Toyoshima; Hiromi Nomura; Takeo Tsuda
Journal:  Nature       Date:  2004-09-26       Impact factor: 49.962

4.  High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.

Authors:  M K Sievert; D S Thiriot; R H Edwards; A E Ruoho
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Vesicular neurotransmitter transporters: from bacteria to humans.

Authors:  S Schuldiner; A Shirvan; M Linial
Journal:  Physiol Rev       Date:  1995-04       Impact factor: 37.312

7.  Comparison of seven different heterologous protein expression systems for the production of the serotonin transporter.

Authors:  Christopher G Tate; Jana Haase; Cara Baker; Marco Boorsma; Francesca Magnani; Yvonne Vallis; D Clive Williams
Journal:  Biochim Biophys Acta       Date:  2003-02-17

8.  Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

Authors:  Y M Wang; R R Gainetdinov; F Fumagalli; F Xu; S R Jones; C B Bock; G W Miller; R M Wightman; M G Caron
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

9.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

10.  Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein.

Authors:  Andrew D Ferguson; Brian M McKeever; Shihua Xu; Douglas Wisniewski; Douglas K Miller; Ting-Ting Yamin; Robert H Spencer; Lin Chu; Feroze Ujjainwalla; Barry R Cunningham; Jilly F Evans; Joseph W Becker
Journal:  Science       Date:  2007-06-28       Impact factor: 47.728

View more
  3 in total

1.  Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis.

Authors:  Dana Yaffe; Ariela Vergara-Jaque; Lucy R Forrest; Shimon Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

2.  Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2.

Authors:  Dana Yaffe; Sebastian Radestock; Yonatan Shuster; Lucy R Forrest; Shimon Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 3.  SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine.

Authors:  Hakeem O Lawal; David E Krantz
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.